Skip to main content

Table 6 Mean (SEM) percentage changes from baseline in Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in PwMS with low disability (EDSS < 4.0) and high disability (EDSS > =4.0)

From: Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study

  1 month 3 months 6 months
  EDSS < 4.0 EDSS > =4.0 EDSS < 4.0 EDSS > =4.0 EDSS < 4.0 EDSS > =4.0
MSSES-Function 3.2% (1.9) 5.4% (7.7) −2.7% (5.1) 1.9% (9.6) 2.5% (3.0) 0.2% (9.5)
MSSES-Control 6.5% (6.5) 13.3% (10.4) 5.8% (6.5) 11.0% (16.6) 23.8%* (8.1) 22.9% (17.7)
IPA-Limitations −6.3% (3.9) −2.0% (3.0) −6.1%** (3.0) −0.6% (4.3) −4.8% (4.0) −1.3% (4.0)
IPA-Problems −4.2% (4.2) −2.9% (3.1) −8.8%** (4.3) −3.7% (4.0) −1.3% (5.3) −3.1% (4.1)
  1. *, P < 0.01; **, 0.05 < P < 0.06 (comparisons with baseline).